We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
301
LKQ Corp
LKQ
$6.69B
$6.43M 0.04%
154,660
-78,887
-34% -$3.53M
BIO icon
302
Bio-Rad Laboratories Class A
BIO
$8.47B
$6.38M 0.04%
23,374
-36,284
-61% -$10.6M
ZLAB icon
303
Zai Lab
ZLAB
$2.1B
$6.33M 0.04%
365,013
-170,000
-32% -$2.99M
KIM icon
304
Kimco Realty
KIM
$17.8B
$6.31M 0.04%
+324,421
New +$6.08M
SRRK icon
305
Scholar Rock
SRRK
$5.86B
$6.2M 0.04%
+744,443
New +$9.1M
LBPH
306
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$6.11M 0.04%
+225,917
New +$4.46M
TNET icon
307
TriNet
TNET
$2.94B
$6.04M 0.04%
60,353
-48,490
-45% -$5.4M
DAY
308
DELISTED
Dayforce
DAY
$6.03M 0.04%
121,523
-67,343
-36% -$3.85M
GTLS
309
DELISTED
Chart Industries
GTLS
$6.01M 0.04%
41,618
PRU icon
310
Prudential Financial
PRU
$42.3B
$5.93M 0.04%
50,615
+7,742
+18% +$894K
ARWR icon
311
Arrowhead Research
ARWR
$12B
$5.93M 0.04%
228,054
EWTX icon
312
Edgewise Therapeutics
EWTX
$4.48B
$5.93M 0.04%
329,000
FDX icon
313
FedEx
FDX
$73.5B
$5.89M 0.04%
19,639
+63
+0.3% +$16.5K
XNCR icon
314
Xencor
XNCR
$1.47B
$5.87M 0.04%
310,019
-341,298
-52% -$7.33M
CMG icon
315
Chipotle Mexican Grill
CMG
$42.6B
$5.79M 0.04%
92,450
+6,450
+8% +$401K
CVS icon
316
CVS Health
CVS
$137B
$5.69M 0.03%
96,405
-195,007
-67% -$12.2M
NET icon
317
Cloudflare
NET
$94.3B
$5.68M 0.03%
68,553
+20,733
+43% +$1.67M
USB icon
318
US Bancorp
USB
$98.9B
$5.64M 0.03%
142,151
+12,257
+9% +$500K
AKAM icon
319
Akamai
AKAM
$16.4B
$5.64M 0.03%
62,576
+5,701
+10% +$551K
KDP icon
320
Keurig Dr Pepper
KDP
$41B
$5.63M 0.03%
168,659
+35,121
+26% +$1.17M
BPMC
321
DELISTED
Blueprint Medicines
BPMC
$5.61M 0.03%
52,066
+12,001
+30% +$1.2M
MGA icon
322
Magna International
MGA
$18.3B
$5.61M 0.03%
133,812
+79,235
+145% +$3.7M
KMI icon
323
Kinder Morgan
KMI
$70.6B
$5.44M 0.03%
273,785
-10,940
-4% -$209K
WMB icon
324
Williams Companies
WMB
$86.6B
$5.43M 0.03%
127,806
+2,922
+2% +$117K
EHC icon
325
Encompass Health
EHC
$11.3B
$5.32M 0.03%
62,026
-2,958
-5% -$248K

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.